Clinical Trial Update: Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated diclofenac sodium topical gel 1% against placebo for efficacy and safety in subjects with acute blunt soft tissue injuries/contusions;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contusion
• Soft Tissue Injury

Drugs mentioned

• diclofenac sodium topical gel, 1% (diclofenac sodium topical gel, 1%)

Snippet

Sponsor: Novartis | Conditions: Acute Blunt Soft Tissue Injuries/Contusions | Phase 3 | Status: COMPLETED | Results posted: 2017-04-19